Skip to main content
. 2022 Aug 2;14(15):3759. doi: 10.3390/cancers14153759

Table 3.

Top 5 clusters with their representative enriched terms (one per cluster) from pathway enrichment analysis. “Count” is the number of genes in the user-provided lists with membership in the given ontology term. “%” is the percentage of all of the user-provided genes that are found in the given ontology term (only input genes with at least one ontology term annotation are included in the calculation). “Log10(P)” is the p-value in log base 10. “Log10(q)” is the multi-test adjusted p-value in log base 10.

GO Description Count % Log10(p) Log10(q) Genes
R-HSA-156711 Polo-like-kinase-mediated events 5 20.83 −7.07 −2.84 CCNB1, CENPF, FOXM1, PLK1, CCNB2, IGF1, TOP2A, TPX2
R-HSA-69273 Cyclin-A/B1/B2-associated events during G2/M transition 6 25 −6.85 −2.84 CCNA2, CCNB1, CDK1, FOXM1, PLK1, CCNB2, CENPF, PCNA, TOP2A, ANLN,
IGF1, DTL, ECT2, TPX2, EDN3, KIF23, NUSAP1, MKI67, EZR
M5893 HALLMARK MITOTIC SPINDLE 12 50 −6.12 −2.42 CDK1, CENPF, ECT2, KIF11, PLK1, TOP2A, EZR, CCNB2, KIF23,
TPX2, NUSAP1, ANLN, CCNA2, MKI67, CCNB1, CKAP2, ASPM
WP2361 Gastric cancer network 1 4 16.67 −3.96 −0.94 CENPF, ECT2, TOP2A, TPX2
GO:0030866 Cortical actin cytoskeleton organization 3 12.5 −3.14 −0.4 ECT2, EZR, ANLN, IGF1, CCT5